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Abstract 
Growth hormone (GH) exerts its cell division-stimulating (mitogenic) effect not directly 
on cells but indirectly through the mediation of a mitogen whose synthesis and release are 
induced by growth hormone. This mitogen is called insulin-like growth factor I (IGF-I). 
The secretion and activity of IGF-I can be influenced by the nutritional status of the 
individual and by many hormones other than GH. GH resistance occurs in human Laron 
type dwarfism due to mutations in the GH receptor (GHR) and a mammalian model for 
GH resistance has been developed in mice through targeted disruption or "knockout" 
(KO) of the GHR. In GHR-KO mice, GH resistance leads to quantitative deficits in 
reproductive development and functions, but does not preclude fertility in either sex 
(Bartke et al., 1999). Secondary consequences of GH resistance in mice include 
hyperprolactinemia, hypoinsulinemia, IGF-I insufficiency, mild hypothyroidism, and 
decreased core body temperature. Many of these phenotypic manifestations are consistent 
with and suggestive of nutritional stress. Sexual maturation and adult reproductive 
function are tightly linked to nutritional status. Delayed puberty onset and retarded 
progression of sexual maturation in GHR-KO mice may be due, at least in part, to 
nutritional stress exacerbated in rapidly growing young and adolescent individuals. 
Dietary sucrose supplementation aimed at alleviating nutritional stress in the juvenile-to­
adult transition period did not advance puberty onset in GHR-KO mice. The current study 
attempts to examine the effects of sucrose supplementation on late stages of sexual 
maturation in GHR-KO mice. Specifically, we tested the hypothesis that dietary sucrose 
supplementation during the juvenile-to-adult transition would promote more rapid 
progression of later stages of sexual maturation and advance maternal age at first 
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conception (MAFC) in female GHR-KO mice. At 65 days post-partum normal and GHR-
KO female mice were randomly assigned to one of four treatment groups: normal 
untreated (N-U, n=15), GHR-KO untreated (KQ-U, n=15), normal sucrose-supplemented 
(N-SS, n=15) and GHR-KO sucrose-supplemented (KO-SS, n=15). Untreated control 
mice received normal lab chow diets throughout the remainder of the study, while treated 
females received standard lab chow supplemented with sucrose (2 parts chow: I part 
sucrose). Five days later females were paired with normal adult males and subsequently 
monitored daily for pregnancy and parturition. Litter size was recorded and pups were 
removed on the day of delivery. Females were sacrificed 7 days post-partum and body, 
uterine, and ovarian weights were recorded. Analysis of variance and Fischer PLSD post 
hoc analysis were used to determine significant effects of genotype, treatment, and 
genotype x treatment interaction between groups, with significance at p<0.05. MAFC 
was significantly affected by genotype (p=O.003), treatment (p=O.034), and genotype x 
treatment interaction (p=0.024). Regardless of treatment, normal mice conceived first 
litters roughly 20 days earlier than untreated GHR-KO females (N-U=83.7 +/- 2.3 days, 
N-SS=84.2 +/- 3.4 days, KO-U=103.6 +/- 5.8 days). MAFC in sucrose supplemented. 
GHR-KO females (KQ-SS=87.0 +/- 2.9 days) did not differ significantly from that ofN-
SS (p=0.58) or from N-U (p=0.51) but was advanced significantly (p=0.008) compared to 
KO-U. These results support our hypothesis and warrant further research that studies the 
mechanism(s) by which sucrose affects the rate of progression of sexual maturation GH 
resistant states. 
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Introduction 
I Growth hormone (GH), secreted by the anterior pituitary, has little or no effect on fetal 
2 . growth, but is the most important hormone for postnatal growth. Growth hormone exerts 
3 its cell division-stimulating (mitogenic) effect not directly on cells but indirectly through 
4 the mediation of a mitogen whose synthesis and release are induced by GH. This mitogen 
5 is called insulin-like growth factor I (IGF-I). The importance of IGF-I in mediating the 
6 major growth-promoting effect of growth hormone is illustrated by the fact that dwarfism 
7 can be due not only to decreased secretion of growth hormone, but also to decreased 
8 production ofIGF-I or failure of the tissues to respond to IGF-I. 
9 In humans, growth hormone insensitivity syndrome, Laron Dwarfism, is due to 
10 genetic mutations that cause the growth hormone receptor to fail to respond to growth 
11 hormone. The result is failure to produce IGF-I in response to growth hormone. Thus 
12 female mice with GH resistance due to targeted disruption of the GH receptor/GH 
13 binding protein gene (GHR-KO mice) have suppressed plasma IGF-I levels, reduced 
14 growth, and the dwarf phenotype (Danilovich et aI., 1999) suggesting that GHR-KO mice 
IS mimic the human condition in many ways. The most notable similarities include growth 
16 retardation, delayed sexual maturation, severely depressed serum IGF-I levels and a 
17 complete inability to utilize GH (List et aI., 2001). 
18 In mice and humans GH resistance leads to quantitative deficits in reproductive 
19 development and functions, but does not preclude fertility in either sex. (Bartke et aI., 
20 1999) The secretion and activity of IGF-I can be influenced by the nutritional status of 
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21 the individual and by many hormones other than growth hormone. Estrogen also 
22 stimulates the secretion of IGF-I by cells of the uterus and ovaries. Growth hormone 
23 (GH), insulin-like growth factor (IGF-I), and prolactin (pRL) can influence various 
24 aspects of reproductive functions in both females and males. Bartke et a1. (1999) suspect 
25 that PRL and the GH-IGF-I axis provide partially overlapping (redundant) regulatory 
26 inputs to the hypothalamic-pituitary-gonadal (HPG) axis, and consequently, targeted 
27 disruption of either signaling pathway has relatively mild consequences on many 
28 functions related to reproduction. Growth hormone and the main mediator of its action, 
29 IGF-I, can exert direct and indirect effects on gonadal function and these actions are 
30 particularly evident during sexual maturation. The GHRlBP -/- (aka GHR-KO) mice do 
31 not tend toward obesity, exhibit normal to low glucose levels, and have severely 
32 decreased insulin levels when compared to normal (+/+) animals (List et a1., 2001). GH 
33 and IGF-I and their receptors are widely distributed throughout the HPG axis, along with 
34 numerous binding proteins and proteases known to regulate GH/IGF bioavailability and 
35 action (Zazcek et a1., 2002). GH antigens are identified in pituitary cells containing FSH 
36 and LH messenger RNAs and GnRH receptors, indicating that either GH cells are 
37 transitory gonadotrophs, or GH is present in these pituitary cells, possibly to control their 
38 function (Chandrashekar et a1., 1999). Furthermore, GH binding protein antigens were 
39 identified in pituitary cells that contained LH and FSH, indicating a paracrine effect of 
40 GH on the function of the gonadotrophs (Chandrashekar et aI., 1999). GH and IGF-I have 
41 been implicated in the following aspects pertinent to female reproduction: I) regulation 
42 of the timing of puberty onset and the progression of sexual maturation, 2) regulation of 
43 GnRH and gonadotropin release from the hypothalamus and pituitary, respectively, and, 
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44 3) modulation of ovarian follicular growth and development, steroidogenesis, and 
45 apoptosis (Zazcek et aI., 2002). In addition, GH and IGF-I influence numerous processes 
46 related to pregnancy including oocyte maturation and fertilization, early embryo 
47 development, implantation, fetal/placental growth and development, and litter size 
48 (Zazcek et aI., 2002). 
49 Fulgeshu et aI. (1997) evaluated the influence of insulin level on the ovarian 
50 response to FSH when inducing ovulation in patients affected by polycystic ovarian 
51 syndrome (peOS) and found that while ovulation rate was similar in normoinsulinemic 
52 and hyperinsulinemic subjects, the incidence of ovarian hyperstimulation was 
53 significantly higher in the latter group. Yoshimura et aI. (1996) conducted a study, which 
54 provided proof that addition ofIGF-I to the perfusate stimulated follicular growth and the 
55 resumption of meiosis in follicular oocytes and increased estradiol production in cultured 
56 rabbit ovaries in a dose dependent manner. 
57 Type I diabetes is associated with abnormalities of the GH-IGF-I axis. Such 
58 abnormalities include decreased circulating levels ofIGF-I (Bartke et aI., 1999). Type I 
59 diabetes has received particular attention because the relative portal insulin deficiency of 
60 this condition is thought to be responsible for the reduced circulating levels of IGF-I 
61 which in turn, through decreased negative feedback, leads to increased secretion of GH. 
62 The metabolic profile of GHR-KO mice suggests these animals may experience some 
63 level of nutritional stress, but to date it has not been established how nutritional stress 
64 effects sexual maturation and reproductive functions m GHR-KO IDlce. 
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I Materials and Method 
2 GHR-KO (-/-) and normal (N, +/+ or +/-) control mice were produced by mating +/- or -/­
3 males to +/- females in our breeding colony, which was derived from our original 
4 GHR/GHBP KO (Zhou et al., I997b) crossed with animals derived from C57BL/6 x C3H 
5 hybrids and thereafter bred in closed colony at the Southern Illinois University animal 
6 facility. Mice were kept in the SlUC vivarium at strict light and temperature conditions, 
7 which included a 12UI2D photoperiod at 22+2° C. Once ther animals reached weaning 
8 age (21 days) they were segregated by sex but not by genotype and housed with up to 
9 five other mice of the same sex per cage. Subsequently ad libitum access to tap water and 
10 standard lab chow (Purina Formulab 5008 Rodent; El Mel Inc., Florissant MO) was 
II given. At 65 days post-partum normal and GHR-KO female mice were randomly 
12 assigned to one of four treatment groups: normal untreated (N-U, n=15), GHR-KO 
13 untreated (KG-U, n=15), normal sucrose-supplemented (N-SS, n=15) and GHR-KO 
14 sucrose-supplemented (KO-SS, n=15). Untreated control normal and GHR-KO female 
15 mice received normal lab chow diets throughout the remainder of the study, while 
16 sucrose supplemented females were fed standard lab chow and sucrose on a ratio of 2 
17 parts chow: I part sucrose. Five days after the sucrose supplemented females were started 
18 on the new 2 parts chow: I part sucrose diet, they were paired with normal adult males 
19 and subsequently monitored daily for vaginal plugs (between 0800 and 1030 am) and 
20 parturition to determine effects of sucrose supplementation on latency to first mating. All 
21 cages contained one GHR-KO female and one normal female to ensure that both GHR­
22 KO and normal females would be similarly exposed to any male effects (e.g. delayed 
23 puberty, male sub-fertility/infertility). The mean age of females at pairing did not differ 
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24 between groups. There is distinct size differences between nonnal males and GHR-KO 
25 females at 65 days post-partum which, contribute to occasional injuries to the female 
26 during mating and consequently a total of 5 GHR-KO females died in the course of the 
27 study because of physical injuries caused by the nonnal males during mating. The date of 
28 delivery and litter size was recorded and pups were removed on the day of delivery. 
29 Females were sacrificed 7 days post-pactum and body, uterine, and ovarian weights were 
30 recorded. Analysis of variance and Fisher post hoc analyses were used to detennine 
31 significant effects of genotype, treatment, and genotype x treatment interaction between 
32 groups with significance at p<0.05. Experiments were approved by the University 
33 Animal Care and Utilization Committee and were conducted in accordance with NIH 
34 (national institute of health) animal care guideline. 
Liti 9 
Results 
To determine the effect of sucrose supplementation on the rate at which sexual 
2 maturation proceeds and fertility is achieved, we analyzed maternal age at fIrst 
3 conception (MAFC) in normal and GHR-KO mice maintained on standard lab chow 
4 (untreated control) diets or sucrose supplemented diets during the juvenile-to-adult 
5 transition period. MAFC was signifIcantly affected by genotype (p=0.003), treatment 
6 (p=O.034), and genotype x treatment interaction (p=O.024) (Fig. I). Regardless of 
7 treatment, normal mice conceived fIrst litters roughly 20 days earlier than untreated 
8 GHR-KO females (N-U=83.7 +/- 2.3 days, N-SS=84.2+/- 3.4 days, KO-U=103.6 +/- 5.8 
9 days). MAFC in sucrose supplemented GHR-KO females (KO-SS=87.0+/- 2.9 days) did 
10 not differ signifIcantly from that of N-SS (p=O.58) or from N-U (p=0.51) but was 
II advanced signifIcantly (p=0.008) compared to MAFC in GHR-KO mice maintained on 
12 the control diet. All normal females in the study conceived and delivered fIrst litters. 
13 Consistent with previous mating studies in GHR-KO mice, a subset (n= 5) of GHR-KO 
14 females died (2 KO-U and 3 KQ-SS) due to mating related trauma and a subset (n=IO) of 
15 GHR-KO females (6 KO-U and 4 KO-SS) failed to conceive when housed continually 
16 with males of proven fertility for 110 or more days (Table I). 
17 For those females that did conceive we used analysis of variance and Fisher post hoc 
18 comparisons to determine signifIcant genotype, treatment, and/or genotype x treatment 
19 interaction effects on litter size between groups. Consistent with previous studies, litter 
20 size was signifIcantly influenced by genotype (p=O.OOI), but no signifIcant effects of 
21 treatment or genotype x treatment interaction was found (p=0.253 and p=0.572, 
22 respectively) (Fig. 2) Regardless of treatment, normal females had larger-sized litter, by 
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23 roughly 2 pups per litter, compared to GHR-KO counterparts (N-U=6.l +/­ 0.4 
24 pupslJitter, N-SS=5.1 +/- 0.6 pupslJitter, KO-U=3.7+/-0.9 pups per litter, and KO-SS=3A 
25 +/- 0.3 pupslJitter). 
26 Because sexual maturation and fertility are intimately tied to nutritional status, which is 
27 reflected in fat stores and body weight, we used similar analyses to detect significant 
28 differences in body weight [at sacrifice] between groups due to genotype, treatment, 
29 and/or genotype x treatment interactions. Genotype, but not treatment or genotype x 
30 treatment interaction, significantly affected body weight at sac (p<0.0001, p=0.58, and 
31 p=O.32, respectively) (Fig. 3). Body weight at sacrifice was similar in normal females, 
32 regardless of treatment (N-U=2l.4 +/- l.Og and N-SS=20.9 +/- 0.5g, p=0.69) and was 
33 roughly 40% greater than that of untreated or sucrose supplemented GHR-KO females, 
34 who did not differ from one another (KO-U=13.3 +/- 0.8g and KO-SS=14.9 +/- lAg, 
35 p=O.35). 
36 Absolute ovarian weight at sacrifice was also significantly affected by genotype 
37 (p<0.0001) but not by treatment (p--o.78) nor by genotype x treatment interactions 
38 (p=0.34) (fig. 4). Absolute ovarian weights of normal mice were similar between 
39 treatment groups (N-U=9.4 +/- 0.6g, N-SS=9.8 +/- 0.4g, p=O.55) and roughly double that 
40 of ovary weights in GHR-KO females on standard or sucrose supplemented diets (KO­
41 U=5.5 +/- 0.6g, KO-SS= 4.7 +/- 0.5g, p=O.46). However, relative ovarian weight (ROW= 
42 ovary weight expressed as a percentage of total body weight) was significantly affected 
43 by genotype (p=O.005) and genotype x treatment interactions (p=O.04). Sucrose 
44 supplementation differentially influenced ROW in normal and GHR-KO mice, producing 
45 slight but not significant increases in ROW in normal mice (N-U=O.044 +/- 0.002% vs. 
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46 N-SS=O.047 +/- 0.002%, p=O.28). In contrast. sucrose supplementation resulted in slight 
47 decreases in GHR-KO mice that tended toward significance (KO-V=0.041 +/- 0.004% 
48 vs. KO-SS= 0.033 +/- 0.004%, p=O.09) and rendered KO-SS females significantly 
49 different from N-V females (p=0.008) and N-SS females (p=0.006). 
50 Analysis of variance revealed no significant effects of genotype (p=O.19), treatment 
51 (p=0.14), nor genotype x treatment interaction (p=0.21) on absolute uterine weight at 
52 sacrifice (fig. 5). However, mean absolute uterine weight at sacrifice in sucrose 
53 supplemented GHR-KO mice was 71.4 +/- 5.2g, while in all other treatment groups mean 
54 absolute uterine weights were approximately 100g (N-V=105.4 +/- 14.lg, N-SS=102.5 
55 +/- 5.3g, and KO-V=104.9 +/- 12.5g). In Fisher post hoc analysis, two-way comparisons 
56 between groups revealed significant differences between KO-SS and N-V groups 
57 (p=0.04), nearly significant differences between KO-SS and N-SS groups (p=0.06) and a 
58 trend toward significant differences between KO-SS and KO-V groups (p=O.lO). Relative 
59 uterine weight (uterine weight expressed as a percentage of total body weight) was 
60 significantly affected by genotype (p=O.009), treatment (p=O.020) and genotype x 
61 treatment interaction (p=O.017). Sucrose supplementation did not affect RVW in normal 
62 mice (N-V=0.49 +/- 0.05g, N-SS=O.49 +/- 0.03g, p=O.96). RVW was greater in untreated 
63 GHR-KO mice (0.80 +/- O.l1g), with this treatment group being significantly different 
64 from both untreated and sucrose-supplemented normal females (p=O.OOl and p=O.OOl, 
65 respectively). Sucrose supplementation reduced RVW in GHR-KO mice (0.51 +/- 0.6g) 
66 such that KO-SS females were significantly different from untreated GHR-KO mice 
67 (p=0.005) but did not differ from untreated or sucrose supplemented normal mice 
68 (p=O.83 and p=O.86, respectively) 
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Table summarizing the number of animals that died, conceived, and didn't conceive. 
Genotype Died Didn't conceive Conceived 
KO-SS 3 4 8 
KO-U 2 6 7 
N-SS 0 0 15 
N-U 0 0 15 
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Figure I: Effect of sucrose supplementation during the juvenile-to-adult transition period 
(beginning at 65 days post-partum) on the progression of sexual maturation, as assessed 
by maternal age at first conception, in normal and growth hormone receptor knockout 
(GHR-KO) mice. Treatment groups= normal untreated control (N-V), GHR-KO 
untreated control (KO-V), normal sucrose supplemented (N-SS), and GHR-KO sucrose 
supplemented (KO-SS) mice. Bars represent mean ±SEM. Letter designations above 
bars indicate significant difference (at ~0.05) between groups with different letter 
designations. 
Treatment groups P value Significance 
ko-ss ko-u 0.0082 S 
ko-ss n-ss 0.5821 
ko-ss n-u 0.5128 
ko-u n-ss 0.0007 S 
ko-u n-u 0.0005 S 
n-ss n-u 0.8998 
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Figure 2 
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Figure 2: Effect of sucrose supplementation during the juvenile-to-adult transition period 
(beginning at 6S days post-partum) on litter size in normal and growth hormone receptor 
knockout (GHR-KO) mice. Treatment groups= normal untreated control (N-V), GHR­
KO untreated control (KO-V), nonnal sucrose supplemented (N-SS), and GHR-KO 
sucrose supplemented (KO-SS) mice. Bars represent mean ±SEM. Letter designations 
above bars indicate significant difference (at ~O.OS) between groups with different letter 
d' .eSlgnatlOns. 
Treatment groups P value Significance 
ko-ss ko-u 0.7219 
ko-ss n-ss 0.0408 S 
ko-ss n-u 0.0017 S 
ko-u n-ss 0.1139 
ko-u n-u 0.0076 S 
n-ss n-u 0.1420 
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Figure 3: Effect of sucrose supplementation during the juvenile-to-adult transition period 
(beginning at 65 days post-partum) on body weight in nonnal and growth honnone 
receptor knockout (GHR-KO) mice. Treatment groups= nonnal untreated control (N-V), 
GHR-KO untreated control (KO-U), nonnal sucrose supplemented (N-SS), and GHR-KO 
sucrose supplemented (KQ-SS) mice. Bars represent mean ±SEM. Letter designations 
above bars indicate significant difference (at P:'S0.05) between groups with different letter 
designations. 
Treatment IlI'OUDS P value Sil!Dificance 
ko-ss ko-u 0.3525 
ko-ss n-ss <0.0001 S 
ko-ss n-u <0.0001 S 
ko-u n-ss <0.0001 S 
ko-u n-u <0.0001 S 
n-ss n-u 0.6894 
Liti 16 
Figure 4 
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Figure 4: Effect of sucrose supplementation during the juvenile-to-adult transition period 
(beginning at 65 days post-partum) on absolute ovary weight in normal and growth 
hormone receptor knockout (GHR-KO) mice. Treatment groups= normal untreated 
control (N-V), GHR-KO untreated control (KQ-V), normal sucrose supplemented (N­
SS), and GHR-KO sucrose supplemented (KO-SS) mice. Bars represent mean ±SEM. 
Letter designations above bars indicate significant difference (at p~0.05) between groups 
with different letter desilffilltions. 
Treatment groups P value Significance 
ko-ss ko-u 0.4556 
ko-ss n-ss <0.0001 S 
ko-ss n-u <0.0001 S 
ko-u n-ss <0.0001 S 
ko-u n-u 0.0002 S 
n-ss n-u 0.5513 
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Figure 5: Effect of sucrose supplementation during the juvenile-to-adult transition period 
(beginning at 65 days post-partum) on relative ovary weight (ROW= ovary weight 
expressed as a percentage of total body weight) in normal and growth hormone receptor 
knockout (GHR-KO) mice. Treatment groups= normal untreated control (N-U), GHR­
KO untreated control (KO-V), normal sucrose supplemented (N-SS), and GHR-KO 
sucrose supplemented (KO-SS) mice. Bars represent mean ± SEM. Letter designations 
above bars indicate significant difference (at PSO.05) between groups with different letter 
desil!Dlltions. 
Treatment l>TOuns P value Significance 
ko-ss ko-u 0.0866 
ko-ss n-ss 0.0006 S 
ko-ss n-u 0.0076 S 
ko-u n-ss 0.1636 
ko-u n-u 0.5617 
n-ss n-u 0.2766 
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Figure 6: Effect of sucrose supplementation during the juvenile-to-adult transition period 
(beginning at 65 days post-partum) on absolute uterine weight in normal and growth 
hormone receptor knockout (GHR-KO) mice. Treatment groups= normal untreated 
control (N-V), GHR-KO untreated control (KO-V), normal sucrose supplemented (N­
SS), and GHR·KO sucrose supplemented (KO-SS) mice. Bars represent mean ±SEM. 
Letter designations above bars indicate significant difference (at p~0.05) between groups 
with different letter designations. 
Treatment groups P value Significance 
ko-ss ko-u 0.0986 
ko-ss n-ss 0.0598 
ko-ss n-u 0.0402 S 
ko-u n-ss 0.8934 
ko-u n-u 0.9754 
n-ss n-u 0.8273 
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Figure 7: Effect of sucrose supplementation during the juvenile-to-adult transition period 
(beginning at 6S days post-partum) on relative uterine weight (RUW= uterine weight 
expressed as a percentage of total body weight) in nonnal and growth honnone receptor 
knockout (GHR-KO) mice. Treatment gmups= normal untreated control (N-U), GHR­
KO untreated control (KO-U), normal sucrose supplemented (N-SS), and GHR-KO 
sucrose supplemented (KO-SS) mice. Bars represent mean ±SEM. Letter designations 
above bars indicate significant difference (at P::OO.OS) between groups with different letter 
d· .e5lgnatlOns. 
Treatment groups P value Significance 
ko-ss ko-u 0.0050 S 
ko-ss n-ss 0.8631 
ko-ss n-u 0.8274 
ko-u n-ss 0.0012 S 
ko-u n-u 0.001l S 
n-ss n-u 0.9563 
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Discussion and conclusion 
Growth hormone, secreted by the anterior pituitary, has little or no effect on fetal 
growth, but is the most important hormone for postnatal growth. Growth hormone 
induces the release oflGF-I, which in tum exerts its mitogenic effects on cells. GHR-KO 
female mice have delayed sexual maturation, which has a negative influence on their 
reproductive functions. To summarize GH and IGF-I have been implicated in the 
following aspects pertinent to female reproduction: 1) regulation of the timing of puberty 
onset and the progression of sexual maturation, 2) regulation of GnRH and gonadotropin 
release from the hypothalamus and pituitary, respectively, and, 3) modulation of ovarian 
follicular growth and development, steroidogenesis, and apoptosis. (Zazcek et al., 2002) 
The present study was undertaken in order to examine the effects of diet sucrose 
supplementation on sexual maturation in GHR-KO mice. 
From the results presented previously one generalization can be made in 
particular: sucrose supplementation speeds up final sexual maturation in GHR-KO female 
mice. There was no significant difference in MAFC in sucrose supplemented GHR-KO 
females compared to N-SS (p=O.58) or to N-U (p=O.51) but it was advanced significantly 
(p=0.008) compared to MAFC in GHR-KO mice maintained on the control diet. 
Treatment group also significantly affected ROWand RUW. There was a significant 
difference in ROW between KO-SS compared to N-SS (p=0.0006) and to N-C 
(p=O.OO76) furthermore there was no significant difference between K0-C compared to 
N-SS (p=0.I636) and N-C (p=0.5617) but ROW was not significantly different between 
Ko-SS and K0-C (p=O.0866). There was no significant difference in RUW for Ko-SS 
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22 compared to N-SS (p=O.8631) or to N-U (p=O.8274) but it RUW was significantly lower 
23 in KO-SS compared to KO-U (p=0.005). 
24 It is known that in women a drastic reduction in the size of the adipose reserve, as 
25 happens in overtrained athletes or in pathological situations is associated with 
26 amenorrhea and infertility, and this association persists until the body mass index returns 
27 to normal values (Casabiell, 2001). Menstrual dysfunction is common in active women, 
28 especially competitive athletes who participate in lean-build sports. Although the 
29 mechanism for this menstrual dysfunction has not yet been identified, it is now clear that 
30 negative energy balance, due to high-energy expenditure and inadequate energy intake, is 
31 a major contributing factor (Manore, 2000). For some athletes, negative energy balance is 
32 due to purposeful energy restriction to either maintain or achieve a low bodyweight. Both 
33 the restrictive energy intake and the exercise-induced menstrual deficiency in active 
34 women that may result can have serious health consequence (Manore, 2002). Eating 
35 disorders during pregnancy are associated with miscarriage, low birth weight, obstetrics 
36 complications and post-partum depression furthermore amenorrhea due to starvation is a 
37 diagnostic criterion for anorexia (James, 2001). Menstrual irregularities are common in 
38 women with bulimia. Inadequate body fat results in inadequate estrogen levels because 
39 estrogen is stored in body fat (James, 2001). Lowered estrogen levels may lead to 
40 infertility in these women with eating disorders. Although anovulation is common, long­
41 term infertility is not. Seventeen percent body fat is required to begin or resume normal 
42 menses (James, 2001). In Type II diabetes, tissues of the body such as muscle, liver and 
43 fat are resistant to the action of insulin (known as insulin resistance) while the pancreas 
44 produces some, but not enough, insulin to overcome this resistance. As a result, blood 
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45 sugar (glucose) backs up in the bloodstream. Insulin receptors and insulin signaling 
46 proteins throughout the central nervous system play an integral role in regulating 
47 metabolism, as well as appetite and fertility (Morris F., 2005). In another study Morris et 
48 a1. (2005) concluded that when considered with previous studies, this study demonstrates 
49 that genetically determined insulin resistance in classical insulin target tissues, such as 
50 muscle and fat, may combine with insulin resistance in non-classical target tissues, such 
51 as the brain and beta cell. This interaction may occur synergistically, resulting in obesity, 
52 insulin resistance, glucose intolerance, and high blood fat levels, leading to the complex 
53 metabolic syndrome associated with type II diabetes (Morris F., 2005). Women with 
54 insulin-dependent diabetes mellitus (Type I Diabetes) who had been diagnosed prior to 
55 menarche had a higher probability of delayed menarche, and were at higher risk for 
56 development of menstrual disturbances, including amenorrhea with subsequent fertility 
57 disorders (Yeshaya A., 1995). 
58 The mechanism by which dietary sucrose normalizes final sexual maturation time 
59 in knockout gene mice is not yet understood. GHR-KO mice are very sensitive to insulin 
60 which is due to the low amount of insulin that they produce and to the up-regulation of 
61 the insulin receptors in their liver (Kimura et a1., 2004). Increased levels ofglucose in the 
62 blood lead to an increase in levels of insulin, which through some negative feedback 
63 mechanism decreases the amount of prolactin (Kimura et a1., 2004). In the present study 
64 while body weights did not differ significantly in those GHR-KO females maintained on 
65 control or sucrose-supplemented diets, the mean body weight of sucrose supplemented 
66 females was numerically higher, by about 10%, than the mean weight of non­
67 supplemented GHR-KO mice. Leptin is a 16kDa protein that is secreted almost 
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68 exclusively by the adipocytes. Therefore increased body fat would in tum increase leptin 
69 secretion. The main action of leptin is to decrease appetite and increase energy 
70 expenditure (Messinis, 1999). Mutations in the ob gene (ob/ob) in mice that lead to leptin 
71 deficiency result in hyperphagia and profound obesity as well as diabetes, insulin 
72 resistance and infertility (Messinis, 1999). Evidence has been provided since the early 
73 1970s that fat mass may directly affect ovulation and fertility. In particular, anorectic 
74 women demonstrate a decreased response of luteinizing hormone (LH) to gonadotrophin­
75 releasing hormone (GnRH) and, as in pre-pubertal women; follicle stimulating hormone 
76 (FSH) response is greater than that of LH (Messinis, 1999). Furthermore a critical body 
77 weight is required for a girl at menarche. All of these observations together with the 
78 recent isolation of leptin, support the hypothesis that leptin is probably the missing link 
79 between body fat and reproduction (Messinis, 1999). Since insulin is known to increase 
80 leptin mRNA in adipocytes, it is possible that insulin may stimulate the secretion of 
81 leptin, and, therefore, leptin may participate in certain cases of peas (Messinis, 1999). 
82 While we did not measure leptin levels in our female mice, this would be an important 
83 parameter to assess in subsequent studies. 
84 Insulin, a pancreatic peptide hormone produced in the 6-cel1s of the islets of 
85 Langerhans, plays a major role in the regulation of carbohydrate, fat, and protein 
86 metabolism. The classical target organs for insulin action are muscle, adipose tissue, and 
87 liver. While the pituitary ovarian regulators, LH and FSH, are of paramount importance 
88 to ovarian function, the insulin-related ovarian regulatory system likewise participates in 
89 normal follicle development. Its alterations may be important in the ovarian dysfunctions 
90 observed in a number of disorders, including diabetes mellitus, obesity, polycystic ovary 
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91 syndrome (peOS), and syndromes of extreme insulin resistance (Poretsky et aI., 1999). In 
92 vitro, insulin stimulates ovarian steroidogenesis by both granulosa and thecal cells, 
93 increasing production of androgens, estrogens, and progesterone (poretsky et aI., 1999). 
94 Another group of studies has examined the effects of food intake or oral or intravenous 
95 administration of glucose on circulating androgen concentrations. In normal women, 
96 Parra et aI. (1995) found an increase in free testosterone and no change in androstendione 
97 after breakfast, but a decline of free testosterone after an oral glucose load. The role of 
98 insulin in the ovary may be summarized as follows: I) insulin receptors are widely 
99 distributed throughout all ovarian compartments, 2) at this time there is no convincing 
100 direct in vivo evidence that hyperinsulinemia acutely stimulates ovarian steroid 
10I production, but there is direct in vitro evidence and indirect in vivo evidence for a 
102 stimulatory effect of insulin on ovarian steroidogenesis, 3) the effects of insulin on 
103 ovulation and the ovary are complex (poretsky et aI., 1999). A threshold level of insulin 
104 is likely to be required for the normal function of the hypothalamic-pituitary-ovarian axis, 
105 either because of the direct stimulatory effects of insulin on this axis or because of the 
106 stimulatory effects of insulin on leptin secretion (both direct, with insulin stimulating 
107 adipocyte production of leptin, and indirect, because of insulin-stimulated lipogenesis 
108 (Poretsky et. ai, 1999). On the other hand, excessive circulating insulin, particularly in the 
109 setting of insulin resistance, may enhance ovarian androgen production and thus may 
110 contribute to the development of anovulation (poretsky et aI., 1999). Insulin may amplifY 
111 its own effects, the effects of IGFs, and those of gonadotropins by up-regulating type 1 
112 IGF receptors and gonadotropin receptors, as well as by inhibiting production of IGFBP­
113 1, both in the liver and ovary (poretsky et aI., 1999). In the setting of insulin resistance 
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114 and hyperinsulinemia, therefore, a cycle of events that leads to a self-perpetuating 
115 amplification of the ovarian effects of insulin and IGFs can develop (poretsky et a!., 
116 1999). While we did not measure plasma insulin in our animals in this study, presumably, 
117 sucrose consumption would at least transiently elevate endogenous insulin levels, and 
118 sucrose supplementation may increase the rate at which sexual maturation proceeds due 
I19 to changes in plasma insulin levels that affect any or all of the aforementioned sites in the 
120 hypothalamic-pituitary-gonadal axis. 
121 Actions of PRL on luteal function depend on species and the stage of the estrous 
122 cycle. In rodents, prolactin can either be luteotrophic after mating or luteolytic in the 
123 absence of a mating stimulus (Freeman, 2000). Ameral et aI. (2003) studied the effect of 
124 prolactin on the insulin signaling pathway in neonatal rat pancreatic islets and they found 
125 that PRL significantly potentiates glucose-induced insulin secretion in islets cultured for 
126 7 days moreover, decreased levels ofPRL in turn increase levels of Activin A. The study 
127 by Tamura et aI. (2000) demonstrated that Activin A stimulated basal GH secretion and 
128 inhibited basa1 PRL secretion in GH3 cells via modulation of the transcription of the GH 
129 and PRL genes. Therefore maybe PRL and Activin A inhibit each other thus when 
130 prolactin levels are low, Activin A levels would be high. Increased Activin levels 
131 stimulate secretion of FSH or increase the number of cells secreting FSH (Miyamoto et 
132 aI., 2003). Miyamoto et aI. (2003) results suggest that (I) Activin A has effects on female 
133 rat pituitary cells that increase not only the amount of FSH secretion per cell, but also the 
134 number of FSH-secreting cells, and (2) Activin A also decreases both the amount ofPRL 
135 secretion per cell and the number of PRL-secreting cells. Since FSH is important in 
136 follicle stimulation, increased amounts of FSH increases stimulation of ovarian follicles 
Liti 26 
137 thus leading to faster cycling and ovulation, which could be how sucrose supplementation 
138 induces earlier final sexual maturation in GHR-KO female mice. Future studies that 
139 measure plasma prolactin and prolactin receptor levels in the hypothalamus, pituitary 
140 gland, ovaries and uterus would elucidate further the role of prolactin in reproduction. 
141 Studies that examine the connection between sucrose nutritional supplementation of 
142 GHR-KO mice and sexual maturation and reproduction are really important because 
143 these findings can help develop new ways of counteracting the negative effects that 
144 diseases such as Type I Diabetes have on the reproductive functions of the people 
145 affected by the disease. Future research that studies the mechanism by which sucrose 
146 affects sexual maturation is warranted. 
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